1. A generic bioanalytical method development strategy and fit-for-purpose qualification to support hERG in vitro sample analysis. (December 2011) Authors: Holme, Paul; Payne, Kirsty; Smith, Sonia; Spence, Mike Journal: Bioanalysis Issue: Volume 3:Number 24(2011) Page Start: 2739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A generic bioanalytical method development strategy and fit-for-purpose qualification to support hERG in vitro sample analysis. (December 2011) Authors: Holme, Paul; Payne, Kirsty; Smith, Sonia; Spence, Mike Journal: Bioanalysis Issue: Volume 3:Number 24(2011) Page Start: 2739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A pharmacokinetic–pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055. (6th July 2017) Authors: Yates, James W T; Holt, Sarah V; Logie, Armelle; Payne, Kirsty; Woods, Karen; Wilkinson, Robert W; Davies, Barry R; Guichard, Sylvie M Journal: British journal of pharmacology Issue: Volume 174:Number 16(2017) Page Start: 2652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗